Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1HIV Infections 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × efavirenz × Clear all
NCT05076682 2025-12-03

Renaissance

Fudan University

Phase 2 Recruiting
80 enrolled
Breast

Triple Negative Breast Neoplasms

NCT00964171 2025-08-28

PANTER

Institut Bergonié

Phase 2 Completed
19 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00964002 2022-05-16

FAVE

Institut Bergonié

Phase 2 Completed
61 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT01878890 2021-01-27

ESCALE

Institut Bergonié

Phase 1 Completed
25 enrolled 11 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00799136 2013-09-12

CATCH

Ontario Clinical Oncology Group (OCOG)

Phase 2 Completed
6 enrolled
LymphoidSarcoma

HIV Infections, Lymphoma, AIDS-Related, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡